We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:INBX
logo

Inhibrx Biosciences (INBX)

Nasdaq • INBX • US45720N1037

83.30Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 30, 2026, ORTEX estimated 39.8% of free float sold short, 12.1 days to cover, cost to borrow 0.47%. Sign up for live short interest data.

Market Cap

1.22b USD | # 4668 in US

Volume

304.22k shares | 30.2m USD

Shares Outstanding

14.72m

Free Float Shares

58.29% | 8.58m

News

INBX key data

Inhibrx Biosciences (Nasdaq: INBX) has a market capitalization of $1.22B. Last close $83.30 (as of 2026-11-17); 52-week range $57.30 to $155.29. ORTEX data as of 2026-10-30: short interest was 39.83% of free float, 12.1 days to cover and the average cost to borrow was 0.47%. Sign up for live short interest data.

  • INBX news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.